Adenosine how supplied storage and handling: Difference between revisions
Ahmed Zaghw (talk | contribs) Created page with "__NOTOC__ {{Adenosine}} {{CMG}}; {{AE}} {{AZ}} ==How Supplied== Adenocard® (adenosine injection) is supplied as a sterile non-pyrogenic solution in normal saline. NDC 0469-..." |
Ahmed Zaghw (talk | contribs) |
||
| Line 5: | Line 5: | ||
==How Supplied== | ==How Supplied== | ||
Adenocard® (adenosine injection) is supplied as a sterile non-pyrogenic solution in normal saline. | Adenocard® (adenosine injection) is supplied as a sterile non-pyrogenic solution in normal saline. | ||
NDC 0469-8234-12 Product Code 823412 | NDC 0469-8234-12 Product Code 823412 | ||
6 mg/2 mL (3 mg/mL) in 2 mL (fill volume) Ansyr® plastic disposable syringe, in a package of ten. | 6 mg/2 mL (3 mg/mL) in 2 mL (fill volume) Ansyr® plastic disposable syringe, in a package of ten. | ||
NDC 0469-8234-14 Product Code 823414 | NDC 0469-8234-14 Product Code 823414 | ||
12 mg/4 mL (3 mg/mL) in 4 mL (fill volume) Ansyr® plastic disposable syringe, in a package of ten. | 12 mg/4 mL (3 mg/mL) in 4 mL (fill volume) Ansyr® plastic disposable syringe, in a package of ten. | ||
Store at controlled room temperature 15º-30ºC (59º-86ºF). | Store at controlled room temperature 15º-30ºC (59º-86ºF). | ||
'''DO NOT REFRIGERATE''' as crystallization may occur. If crystallization has occurred, dissolve crystals by warming to room temperature. The solution must be clear at the time of use. | '''DO NOT REFRIGERATE''' as crystallization may occur. If crystallization has occurred, dissolve crystals by warming to room temperature. The solution must be clear at the time of use. | ||
Contains no preservatives. Discard unused portion. | Contains no preservatives. Discard unused portion. | ||
May require needle or blunt. To prevent needle-stick injuries, needles should not be recapped, purposely bent or broken by hand. | May require needle or blunt. To prevent needle-stick injuries, needles should not be recapped, purposely bent or broken by hand. | ||
Rx Only<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = ADENOCARD (ADENOSINE) SOLUTION [ASTELLAS PHARMA US, INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f0e32589-dad9-4887-8481-bcf7f6618466 | publisher = | date = | accessdate = }}</ref> | Rx Only<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = ADENOCARD (ADENOSINE) SOLUTION [ASTELLAS PHARMA US, INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f0e32589-dad9-4887-8481-bcf7f6618466 | publisher = | date = | accessdate = }}</ref> | ||
Revision as of 18:18, 11 March 2014
| Adenosine |
|---|
| ADENOCARD®, ADENOSCAN® FDA Package Insert |
| Indications and Usage |
| Dosage and Administration |
| Contraindications |
| Warnings and Precautions |
| Adverse Reactions |
| Drug Interactions |
| Use in Specific Populations |
| Overdosage |
| Description |
| Clinical Pharmacology |
| Nonclinical Toxicology |
| Clinical Studies |
| How Supplied/Storage and Handling |
| Labels and Packages |
| Clinical Trials on Adenosine |
| ClinicalTrials.gov |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]
How Supplied
Adenocard® (adenosine injection) is supplied as a sterile non-pyrogenic solution in normal saline.
NDC 0469-8234-12 Product Code 823412
6 mg/2 mL (3 mg/mL) in 2 mL (fill volume) Ansyr® plastic disposable syringe, in a package of ten.
NDC 0469-8234-14 Product Code 823414
12 mg/4 mL (3 mg/mL) in 4 mL (fill volume) Ansyr® plastic disposable syringe, in a package of ten.
Store at controlled room temperature 15º-30ºC (59º-86ºF).
DO NOT REFRIGERATE as crystallization may occur. If crystallization has occurred, dissolve crystals by warming to room temperature. The solution must be clear at the time of use.
Contains no preservatives. Discard unused portion.
May require needle or blunt. To prevent needle-stick injuries, needles should not be recapped, purposely bent or broken by hand.
Rx Only[1]
References
Adapted from the FDA Package Insert.